Slower AI spending could ignite a 'vicious' downturn for chipmakers, Nvidia supplier says
Advantest CEO Doug Lefever told the Financial Times that AI smartphones could justify the data-center spending spree that is ...
De Beers builds up largest diamond stockpile since 2008 crisis as demand slumps, report says
De Beers has accumulated the biggest stockpile of diamonds since 2008, the Financial Times reported. Weak demand and rising ...
Stock market today: Indexes close mixed as traders hold out hope for a Santa Claus rally
The Dow closed slightly higher on Thursday while the Nasdaq and S&P 500 closed lower in the second day of a so-called Santa ...
Stock market today: Indexes edge lower in first trading day after Christmas
Indexes fell in their first trading day after Christmas as traders hope for a so-called Santa Clause rally to propel markets ...
Why the stunning rally in stocks this year could be followed by a 'hangover,' according to ...
2024 was a terrific year for the stock market. The euphoric postelection rally, however, could lead to a near-term "hangover" ...
Toyota stock surges 9% after report says the carmaker aims to double profitability
Toyota shares soared Thursday after Nikkei reported the company aims to double its return on equity target to 20%, citing an ...
'What a difference a year makes': Stocks in this sector are set to surge in 2025 after a ...
Citi analysts forecast 19% earnings growth for the healthcare sector in 2025 amid improving fundamentals and a boom in weight ...
Orinoquia Real Estate’s Strategic Asset Sale in Málaga
Orinoquia Real Estate SOCIMI SA (FR:MLORQ) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top ...
Samsung to reportedly cut 2025 foldable phone targets, DigiTimes reports
Samsung (SSNLF) plans to raise shipments of its Galaxy S series in 2025, while cutting its targets for the Galaxy Z series as the company moves ...
Johnson & Johnson licensing STAT6 program from Kaken Pharmaceutical
Johnson & Johnson announced that it has entered into an exclusive licensing agreement for the global development, manufacturing and ...
Anavex Life Sciences: Buy Rating Driven by European Approval Prospects and Strong Financial ...
Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Anavex Life Sciences (AVXL – Research Report), boosting the price target to ...
Business Insider18 小时
REALITES Announces 2025 Financial Schedule and Achievements
Realites SCA (FR:ALREA) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert ...